Strong associations of serum selenoprotein P with all-cause mortality and mortality due to cancer, cardiovascular, respiratory and gastrointestinal diseases in older German adults.
Ageing
Biomarker
Cohort study
Mortality
Selenium
Selenoprotein P
Journal
European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062
Informations de publication
Date de publication:
10 Jan 2024
10 Jan 2024
Historique:
received:
21
03
2023
accepted:
11
12
2023
medline:
10
1
2024
pubmed:
10
1
2024
entrez:
10
1
2024
Statut:
aheadofprint
Résumé
Selenium is an essential trace mineral. The main function of selenoprotein P (SELENOP) is to transport selenium but it has also been ascribed anti-oxidative effects. To assess the association of repeated measurements of serum SELENOP concentration with all-cause and cause-specific mortality serum SELENOP was measured at baseline and 5-year follow-up in 7,186 and 4,164 participants of the ESTHER study, a German population-based cohort aged 50-74 years at baseline. During 17.3 years of follow-up, 2,126 study participants (30%) died. The relationship of serum SELENOP concentration with all-cause mortality was L-shaped, with mortality being significantly higher at SELENOP concentrations < 4.1 mg/L, which is near the bottom tertile's cut-off (4.2 mg/L). All-cause mortality of participants in the bottom SELENOP tertile was significantly increased compared to subjects in the top tertile (hazard ratio [95% confidence interval]: 1.35 [1.21-1.50]). SELENOP in the bottom tertile was further associated with increased cardiovascular mortality (1.24 [1.04-1.49]), cancer mortality (1.31 [1.09-1.58]), respiratory disease mortality (2.06 [1.28-3.32]) and gastrointestinal disease mortality (2.04 [1.25-3.32]). The excess risk of all-cause mortality for those in the bottom SELENOP tertile was more than twice as strong in men as in women (interaction of SELENOP and sex; p = 0.008). In this large cohort study, serum SELENOP concentration was inversely associated with all-cause and cause-specific mortality. Consistent inverse associations with multiple mortality outcomes might be explained by an impaired selenium transport and selenium deficiency in multiple organs. Trials testing the efficacy of selenium supplements in subjects with low baseline SELENOP concentration are needed. Retrospectively registered in the German Clinical Trials Register on Feb 14, 2018 (ID: DRKS00014028).
Sections du résumé
BACKGROUND
BACKGROUND
Selenium is an essential trace mineral. The main function of selenoprotein P (SELENOP) is to transport selenium but it has also been ascribed anti-oxidative effects.
METHODS
METHODS
To assess the association of repeated measurements of serum SELENOP concentration with all-cause and cause-specific mortality serum SELENOP was measured at baseline and 5-year follow-up in 7,186 and 4,164 participants of the ESTHER study, a German population-based cohort aged 50-74 years at baseline.
RESULTS
RESULTS
During 17.3 years of follow-up, 2,126 study participants (30%) died. The relationship of serum SELENOP concentration with all-cause mortality was L-shaped, with mortality being significantly higher at SELENOP concentrations < 4.1 mg/L, which is near the bottom tertile's cut-off (4.2 mg/L). All-cause mortality of participants in the bottom SELENOP tertile was significantly increased compared to subjects in the top tertile (hazard ratio [95% confidence interval]: 1.35 [1.21-1.50]). SELENOP in the bottom tertile was further associated with increased cardiovascular mortality (1.24 [1.04-1.49]), cancer mortality (1.31 [1.09-1.58]), respiratory disease mortality (2.06 [1.28-3.32]) and gastrointestinal disease mortality (2.04 [1.25-3.32]). The excess risk of all-cause mortality for those in the bottom SELENOP tertile was more than twice as strong in men as in women (interaction of SELENOP and sex; p = 0.008).
CONCLUSIONS
CONCLUSIONS
In this large cohort study, serum SELENOP concentration was inversely associated with all-cause and cause-specific mortality. Consistent inverse associations with multiple mortality outcomes might be explained by an impaired selenium transport and selenium deficiency in multiple organs. Trials testing the efficacy of selenium supplements in subjects with low baseline SELENOP concentration are needed.
TRIAL REGISTRATION
BACKGROUND
Retrospectively registered in the German Clinical Trials Register on Feb 14, 2018 (ID: DRKS00014028).
Identifiants
pubmed: 38198038
doi: 10.1007/s10654-023-01091-4
pii: 10.1007/s10654-023-01091-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Labunskyy VM, Gladyshev VN. Role of reactive oxygen species-mediated signaling in aging. Antioxid Redox Signal. 2013;19(12):1362–72. https://doi.org/10.1089/ars.2012.4891
doi: 10.1089/ars.2012.4891
pubmed: 22901002
pmcid: 3791051
Hinojosa Reyes L, Marchante-Gayon JM, Garcia Alonso JI, Sanz-Medel A. Quantitative speciation of selenium in human serum by affinity chromatography coupled to post-column isotope dilution analysis ICP-MS. J Anal at Spectrom. 2003;18:1210–6. https://doi.org/10.1039/B305455A
doi: 10.1039/B305455A
Letsiou S, Nomikos T, Panagiotakos DB, Pergantis SA, Fragopoulou E, Pitsavos C, Stefanadis C, Antonopoulou S. Gender-specific distribution of selenium to serum selenoproteins: associations with total selenium levels, age, Smoking, body mass index, and physical activity. BioFactors. 2014;40:524–35. https://doi.org/10.1002/biof.1176
doi: 10.1002/biof.1176
pubmed: 25185791
Schomburg L, Selenoprotein. P - selenium transport protein, enzyme and biomarker of selenium status. Free Radic Biol Med. 2022;191:150–63. https://doi.org/10.1016/j.freeradbiomed.2022.08.022
doi: 10.1016/j.freeradbiomed.2022.08.022
pubmed: 36067902
Hurst R, Armah CN, Dainty JR, Hart DJ, Teucher B, Goldson AJ, Broadley MR, Motley AK, Fairweather-Tait SJ. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2010;91:923–31. https://doi.org/10.3945/ajcn.2009.28169
doi: 10.3945/ajcn.2009.28169
pubmed: 20181815
pmcid: 2844680
Toh P, Nicholson JL, Vetter AM, Berry MJ, Torres DJ. Selenium in Bodily Homeostasis: Hypothalamus, hormones, and highways of communication. Int J Mol Sci. 2022;23. https://doi.org/10.3390/ijms232315445
Sunde RA. Selenium regulation of selenoprotein enzyme activity and transcripts in a pilot study with founder strains from the Collaborative Cross. PLoS ONE. 2018;13:e0191449. https://doi.org/10.1371/journal.pone.0191449
doi: 10.1371/journal.pone.0191449
pubmed: 29338053
pmcid: 5770059
McCann JC, Ames BN. Adaptive dysfunction of selenoproteins from the perspective of the triage theory: why modest selenium deficiency may increase risk of Diseases of aging. FASEB J. 2011;25:1793–814. https://doi.org/10.1096/fj.11-180885
doi: 10.1096/fj.11-180885
pubmed: 21402715
Schomburg L, Schweizer U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim Biophys Acta. 2009;1790:1453–62. https://doi.org/10.1016/j.bbagen.2009.03.015
doi: 10.1016/j.bbagen.2009.03.015
pubmed: 19328222
Esposito LA, Kokoszka JE, Waymire KG, Cottrell B, MacGregor GR, Wallace DC. Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radic Biol Med. 2000;28:754–66. https://doi.org/10.1016/s0891-5849(00)00161-1
doi: 10.1016/s0891-5849(00)00161-1
pubmed: 10754271
pmcid: 3049813
Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and Disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;15:1957–97. https://doi.org/10.1089/ars.2010.3586
doi: 10.1089/ars.2010.3586
pubmed: 21087145
pmcid: 3159114
Jin RC, Mahoney CE, Coleman Anderson L, Ottaviano F, Croce K, Leopold JA, Zhang YY, Tang SS, Handy DE, Loscalzo J. Glutathione peroxidase-3 deficiency promotes platelet-dependent Thrombosis in vivo. Circulation. 2011;123:1963–73. https://doi.org/10.1161/circulationaha.110.000034
doi: 10.1161/circulationaha.110.000034
pubmed: 21518981
pmcid: 3107543
Restuadi R, Steyn FJ, Kabashi E, Ngo ST, Cheng FF, Nabais MF, Thompson MJ, Qi T, Wu Y, Henders AK, et al. Functional characterisation of the Amyotrophic Lateral Sclerosis risk locus GPX3/TNIP1. Genome Med. 2022;14. https://doi.org/10.1186/s13073-021-01006-6
Chang C, Worley BL, Phaëton R, Hempel N. Extracellular glutathione peroxidase GPx3 and its role in Cancer. Cancers (Basel). 2020;12. https://doi.org/10.3390/cancers12082197
Zhang L, Zeng H, Cheng WH. Beneficial and paradoxical roles of selenium at nutritional levels of intake in healthspan and longevity. Free Radic Biol Med. 2018. https://doi.org/10.1016/j.freeradbiomed.2018.05.067
doi: 10.1016/j.freeradbiomed.2018.05.067
pubmed: 30599261
pmcid: 6345541
Wang N, Tan HY, Li S, Xu Y, Guo W, Feng Y. Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant. Oxid Med Cell Longev 2017;2017:7478523. https://doi.org/10.1155/2017/7478523
Barja G. Updating the mitochondrial free radical theory of aging: an integrated view, key aspects, and confounding concepts. Antioxid Redox Signal. 2013;19:1420–45. https://doi.org/10.1089/ars.2012.5148
doi: 10.1089/ars.2012.5148
pubmed: 23642158
pmcid: 3791058
Schöttker B, Brenner H, Jansen EH, Gardiner J, Peasey A, Kubinova R, Pajak A, Topor-Madry R, Tamosiunas A, Saum KU, et al. Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data. BMC Med. 2015;13. https://doi.org/10.1186/s12916-015-0537-7
Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–41. https://doi.org/10.1016/s0140-6736(00)02490-9
doi: 10.1016/s0140-6736(00)02490-9
pubmed: 10963212
Rayman MP. Selenium and human health. Lancet. 2012;379:1256–68. https://doi.org/10.1016/s0140-6736(11)61452-9
doi: 10.1016/s0140-6736(11)61452-9
pubmed: 22381456
Wolters M, Hermann S, Golf S, Katz N, Hahn A. Selenium and antioxidant vitamin status of elderly German women. Eur J Clin Nutr. 2005;60:85. https://doi.org/10.1038/sj.ejcn.1602271
doi: 10.1038/sj.ejcn.1602271
Goyal A, Terry MB, Siegel AB. Serum antioxidant nutrients, vitamin A, and mortality in U.S. adults. Cancer Epidemiol Biomarkers Prev. 2013;22:2202–11. https://doi.org/10.1158/1055-9965.epi-13-0381
doi: 10.1158/1055-9965.epi-13-0381
pubmed: 23897583
pmcid: 4026170
Xing X, Xu M, Yang L, Shao C, Wang Y, Qi M, Niu X, Gao D. Association of selenium and cadmium with Heart Failure and mortality based on the National Health and Nutrition Examination Survey. J Hum Nutr Diet. 2023;36:1496–506. https://doi.org/10.1111/jhn.13107
doi: 10.1111/jhn.13107
pubmed: 36321401
Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and Respiratory Disease mortality in a large cohort study. Am J Clin Nutr. 2013;97:782–93. https://doi.org/10.3945/ajcn.112.047712
doi: 10.3945/ajcn.112.047712
pubmed: 23446902
Zhu A, Kuznia S, Niedermaier T, Holleczek B, Schöttker B, Brenner H. Vitamin D-binding protein, total, nonbioavailable, bioavailable, and free 25-hydroxyvitamin D, and mortality in a large population-based cohort of older adults. J Intern Med. 2022;292:463–76. https://doi.org/10.1111/joim.13494
doi: 10.1111/joim.13494
pubmed: 35373871
Kahl H, Holling H, Kamtsiuris P. [Utilization of health screening studies and measures for health promotion]. Gesundheitswesen 1999, 61 Spec No:S163-8, S163-S168.
Neuhauser H, Diederichs C, Boeing H, Felix SB, Jünger C, Lorbeer R, Meisinger C, Peters A, Völzke H, Weikert C, et al. Hypertension in Germany. Dtsch Arztebl Int. 2016;113:809–15. https://doi.org/10.3238/arztebl.2016.0809
doi: 10.3238/arztebl.2016.0809
pubmed: 28073425
pmcid: 5241792
Icks A, Moebus S, Feuersenger A, Haastert B, Jöckel KH, Giani G. Diabetes prevalence and association with social status–widening of a social gradient? German national health surveys 1990–1992 and 1998. Diabetes Res Clin Pract. 2007;78:293–7. https://doi.org/10.1016/j.diabres.2007.04.005
doi: 10.1016/j.diabres.2007.04.005
pubmed: 17532522
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui III, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511. https://www.ahajournals.org/doi/10.1161/01.CIR.0000052939.59093.45
doi: 10.1161/01.CIR.0000052939.59093.45
pubmed: 12551878
Schöttker B, Jansen EH, Haug U, Schomburg L, Köhrle J, Brenner H. Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PLoS ONE. 2012;7:e48774. https://doi.org/10.1371/journal.pone.0048774
doi: 10.1371/journal.pone.0048774
pubmed: 23133659
pmcid: 3486791
Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington DC: National Academy Press; 2011.
Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, et al. New Creatinine- and cystatin C-Based equations to Estimate GFR without Race. N Engl J Med. 2021;385:1737–49. https://doi.org/10.1056/NEJMoa2102953
doi: 10.1056/NEJMoa2102953
pubmed: 34554658
pmcid: 8822996
Hybsier S, Schulz T, Wu Z, Demuth I, Minich WB, Renko K, Rijntjes E, Kohrle J, Strasburger CJ, Steinhagen-Thiessen E, et al. Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P. Redox Biol. 2017;11:403–14. https://doi.org/10.1016/j.redox.2016.12.025
doi: 10.1016/j.redox.2016.12.025
pubmed: 28064116
Ballihaut G, Kilpatrick LE, Davis WC. Detection, identification, and quantification of selenoproteins in a candidate human plasma standard reference material. Anal Chem. 2011;83:8667–74. https://doi.org/10.1021/ac2021147
doi: 10.1021/ac2021147
pubmed: 22007999
SAS OnlineDoc® Version 8. Chapter 49: The PHREG procedure. Institute Inc SAS, Cary, NC, USA. 2023. p. 2622–2635. http://www.math.wpi.edu/saspdf/stat/chap49.pdf . Accessed Dec 2023.
Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037–57. https://doi.org/10.1002/sim.3841
doi: 10.1002/sim.3841
pubmed: 20087875
Müller SM, Dawczynski C, Wiest J, Lorkowski S, Kipp AP, Schwerdtle T. Functional biomarkers for the Selenium Status in a human nutritional intervention study. Nutrients. 2020;12. https://doi.org/10.3390/nu12030676
Schomburg L, Orho-Melander M, Struck J, Bergmann A, Melander O. Selenoprotein-P Deficiency predicts Cardiovascular Disease and Death. Nutrients. 2019;11. https://doi.org/10.3390/nu11081852
Brodin O, Hackler J, Misra S, Wendt S, Sun Q, Laaf E, Stoppe C, Björnstedt M, Schomburg L. Selenoprotein P as Biomarker of Selenium Status in clinical trials with therapeutic dosages of Selenite. Nutrients. 2020;12. https://doi.org/10.3390/nu12041067
Demircan K, Bengtsson Y, Sun Q, Brange A, Vallon-Christersson J, Rijntjes E, Malmberg M, Saal LH, Rydén L, Borg Å, et al. Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following Breast cancer diagnosis: a multicentre cohort study. Redox Biol. 2021;47:102145. https://doi.org/10.1016/j.redox.2021.102145
doi: 10.1016/j.redox.2021.102145
pubmed: 34563873
pmcid: 8476451
Hughes DJ, Fedirko V, Jenab M, Schomburg L, Méplan C, Freisling H, Bueno-de-Mesquita HB, Hybsier S, Becker NP, Czuban M, et al. Selenium status is associated with Colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort. Int J Cancer. 2015;136:1149–61. https://doi.org/10.1002/ijc.29071
doi: 10.1002/ijc.29071
pubmed: 25042282
Al-Mubarak AA, Grote Beverborg N, Suthahar N, Gansevoort RT, Bakker SJL, Touw DJ, de Boer RA, van der Meer P, Bomer N. High selenium levels associate with reduced risk of mortality and new-onset Heart Failure: data from PREVEND. Eur J Heart Fail. 2022;24:299–307. https://doi.org/10.1002/ejhf.2405
doi: 10.1002/ejhf.2405
pubmed: 34931411
Isobe Y, Asakura H, Tsujiguchi H, Kannon T, Takayama H, Takeshita Y, Ishii KA, Kanamori T, Hara A, Yamashita T, et al. Alcohol intake is Associated with elevated serum levels of selenium and selenoprotein P in humans. Front Nutr. 2021;8:633703. https://doi.org/10.3389/fnut.2021.633703
doi: 10.3389/fnut.2021.633703
pubmed: 33693023
pmcid: 7937717
Rasmussen LB, Hollenbach B, Laurberg P, Carlé A, Hög A, Jørgensen T, Vejbjerg P, Ovesen L, Schomburg L. Serum selenium and selenoprotein P status in adult Danes – 8-year followup. J Trace Elem Med Biol. 2009;23:265–71. https://doi.org/10.1016/j.jtemb.2009.03.009
doi: 10.1016/j.jtemb.2009.03.009
pubmed: 19747622
Lloyd B, Lloyd RS, Clayton BE. Effect of Smoking, alcohol, and other factors on the selenium status of a healthy population. J Epidemiol Community Health. 1983;37:213–7. https://doi.org/10.1136/jech.37.3.213
doi: 10.1136/jech.37.3.213
pubmed: 6619720
pmcid: 1052295
Ray AL, Semba RD, Walston J, Ferrucci L, Cappola AR, Ricks MO, Xue QL, Fried LP. Low serum selenium and total carotenoids predict mortality among older women living in the community: the women’s health and aging studies. J Nutr. 2006;136:172–6. https://doi.org/10.1093/jn/136.1.172
doi: 10.1093/jn/136.1.172
pubmed: 16365078
Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008;168:404–10. https://doi.org/10.1001/archinternmed.2007.74
doi: 10.1001/archinternmed.2007.74
pubmed: 18299496
Zhao S, Wang S, Yang X, Shen L. Dose-response relationship between multiple trace elements and risk of all-cause mortality: a prospective cohort study. Front Nutr. 2023;10:1205537. https://doi.org/10.3389/fnut.2023.1205537
doi: 10.3389/fnut.2023.1205537
pubmed: 37533572
pmcid: 10391637
Marniemi J, Järvisalo J, Toikka T, Räihä I, Ahotupa M, Sourander L. Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular Disease mortality in an elderly population. Int J Epidemiol. 1998;27:799–807. https://doi.org/10.1093/ije/27.5.799
doi: 10.1093/ije/27.5.799
pubmed: 9839736
Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, Fan JH, Gunter EW, Taylor PR, Mark SD. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, Heart Disease, stroke, and total death. Am J Clin Nutr. 2004;79:80–5. https://doi.org/10.1093/ajcn/79.1.80
doi: 10.1093/ajcn/79.1.80
pubmed: 14684401
González S, Huerta JM, Fernández S, Patterson AM, Lasheras C. Homocysteine increases the risk of mortality in elderly individuals. Br J Nutr. 2007;97:1138–43. https://doi.org/10.1017/s0007114507691958
doi: 10.1017/s0007114507691958
pubmed: 17367569
Suadicani P, Hein HO, Gyntelberg F. Serum selenium level and risk of Lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study. Eur Respir J. 2012;39:1443–8. https://doi.org/10.1183/09031936.00102711
doi: 10.1183/09031936.00102711
pubmed: 22034648
Kilander L, Berglund L, Boberg M, Vessby B, Lithell H. Education, lifestyle factors and mortality from Cardiovascular Disease and cancer. A 25-year follow-up of Swedish 50-year-old men. Int J Epidemiol. 2001;30:1119–26. https://doi.org/10.1093/ije/30.5.1119
doi: 10.1093/ije/30.5.1119
pubmed: 11689532
Akbaraly NT, Arnaud J, Hininger-Favier I, Gourlet V, Roussel AM, Berr C. Selenium and mortality in the elderly: results from the EVA study. Clin Chem. 2005;51:2117–23. https://doi.org/10.1373/clinchem.2005.055301
doi: 10.1373/clinchem.2005.055301
pubmed: 16123147
Walston J, Xue Q, Semba RD, Ferrucci L, Cappola AR, Ricks M, Guralnik J, Fried LP. Serum antioxidants, inflammation, and total mortality in older women. Am J Epidemiol. 2006;163:18–26. https://doi.org/10.1093/aje/kwj007
doi: 10.1093/aje/kwj007
pubmed: 16306311
Lauretani F, Semba RD, Bandinelli S, Ray AL, Ruggiero C, Cherubini A, Guralnik JM, Ferrucci L. Low plasma selenium concentrations and mortality among older community-dwelling adults: the InCHIANTI Study. Aging Clin Exp Res. 2008;20:153–8. https://doi.org/10.1007/BF03324762
doi: 10.1007/BF03324762
pubmed: 18431083
pmcid: 2746419
Bates CJ, Hamer M, Mishra GD. Redox-modulatory vitamins and minerals that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of people aged 65 years and over. Br J Nutr. 2011;105:123–32. https://doi.org/10.1017/s0007114510003053
doi: 10.1017/s0007114510003053
pubmed: 20807458
pmcid: 3361131
Alehagen U, Johansson P, Bjornstedt M, Rosen A, Post C, Aaseth J. Relatively high mortality risk in elderly Swedish subjects with low selenium status. Eur J Clin Nutr. 2016;70:91–6. https://doi.org/10.1038/ejcn.2015.92
doi: 10.1038/ejcn.2015.92
pubmed: 26105108
Giovannini S, Onder G, Lattanzio F, Bustacchini S, Di Stefano G, Moresi R, Russo A, Bernabei R, Landi F. Selenium concentrations and mortality among Community-Dwelling older adults: results from IlSIRENTE Study. J Nutr Health Aging. 2018;22:608–12. https://doi.org/10.1007/s12603-018-1021-9
doi: 10.1007/s12603-018-1021-9
pubmed: 29717761
Virtamo J, Valkeila E, Alfthan G, Punsar S, Huttunen JK, Karvonen MJ. Serum selenium and the risk of coronary Heart Disease and Stroke. Am J Epidemiol. 1985;122:276–82. https://doi.org/10.1093/oxfordjournals.aje.a114099
doi: 10.1093/oxfordjournals.aje.a114099
pubmed: 4014210
Shi L, Yuan Y, Xiao Y, Long P, Li W, Yu Y, Liu Y, Liu K, Wang H, Zhou L, et al. Associations of plasma metal concentrations with the risks of all-cause and Cardiovascular Disease mortality in Chinese adults. Environ Int. 2021;157. https://doi.org/10.1016/j.envint.2021.106808
Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, van Laar A, de Bruin M, Hermus RJ, Valkenburg HA. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr. 1987;45:462–8. https://doi.org/10.1093/ajcn/45.2.462
doi: 10.1093/ajcn/45.2.462
pubmed: 3812345
Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P. Association between cardiovascular death and Myocardial Infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982;2:175–9. https://doi.org/10.1016/s0140-6736(82)91028-5
doi: 10.1016/s0140-6736(82)91028-5
pubmed: 6123886
Criqui MH, Bangdiwala S, Goodman DS, Blaner WS, Morris JS, Kritchevsky S, Lippel K, Mebane I, Tyroler HA. Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. Ann Epidemiol. 1991;1:385–93. https://doi.org/10.1016/1047-2797(91)90008-z
doi: 10.1016/1047-2797(91)90008-z
pubmed: 1669519
Kornitzer M, Valente F, De Bacquer D, Neve J, De Backer G. Serum selenium and cancer mortality: a nested case-control study within an age- and sex-stratified sample of the Belgian adult population. Eur J Clin Nutr. 2004;58:98–104. https://doi.org/10.1038/sj.ejcn.1601754
doi: 10.1038/sj.ejcn.1601754
pubmed: 14679373
Kok FJ, de Bruijn AM; Hofman, A.; Vermeeren, R.; Valkenburg, H.A. Is serum selenium a risk factor for cancer in men only? Am J Epidemiol. 1987;125:12–16. https://doi.org/10.1093/oxfordjournals.aje.a114493
Brown DG, Burk RF. Selenium retention in tissues and sperm of rats fed a Torula yeast diet. J Nutr. 1973;103:102–8. https://doi.org/10.1093/jn/103.1.102
doi: 10.1093/jn/103.1.102
pubmed: 4682443
Cai X, Wang C, Yu W, Fan W, Wang S, Shen N, Wu P, Li X, Wang F. Selenium exposure and Cancer risk: an updated Meta-analysis and Meta-regression. Sci Rep. 2016;6. https://doi.org/10.1038/srep19213
Whanger PD. Selenium and its relationship to cancer: an update. Br J Nutr. 2004;91:11–28. https://doi.org/10.1079/bjn20031015
doi: 10.1079/bjn20031015
pubmed: 14748935
Xiang S, Dai Z, Man C, Fan Y. Circulating Selenium and Cardiovascular or all-cause mortality in the General Population: a Meta-analysis. Biol Trace Elem Res. 2020;195:55–62. https://doi.org/10.1007/s12011-019-01847-8
doi: 10.1007/s12011-019-01847-8
pubmed: 31368032
Kuria A, Tian H, Li M, Wang Y, Aaseth JO, Zang J, Cao Y. Selenium status in the body and Cardiovascular Disease: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2021;61:3616–25. https://doi.org/10.1080/10408398.2020.1803200
doi: 10.1080/10408398.2020.1803200
pubmed: 32799545
Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D’Amico R, Crespi CM. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018;1(Cd005195). https://doi.org/10.1002/14651858.CD005195.pub4
Jenkins DJA, Kitts D, Giovannucci EL, Sahye-Pudaruth S, Paquette M, Blanco Mejia S, Patel D, Kavanagh M, Tsirakis T, Kendall CWC, et al. Selenium, antioxidants, Cardiovascular Disease, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2020;112:1642–52. https://doi.org/10.1093/ajcn/nqaa245
doi: 10.1093/ajcn/nqaa245
pubmed: 33053149
pmcid: 7727482
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al. Effect of selenium and vitamin E on risk of Prostate cancer and other cancers: the selenium and vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39–51. https://doi.org/10.1001/jama.2008.864
doi: 10.1001/jama.2008.864
pubmed: 19066370
Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New zealanders. Am J Clin Nutr. 1999;70:896–903. https://doi.org/10.1093/ajcn/70.5.896
doi: 10.1093/ajcn/70.5.896
pubmed: 10539752
Yu Z, Zhang F, Xu C, Wang Y. Association between circulating antioxidants and longevity: insight from mendelian randomization study. Bio Med Res Int. 2022;2022:4012603. https://doi.org/10.1155/2022/4012603
Cornish AJ, Law PJ, Timofeeva M, Palin K, Farrington SM, Palles C, Jenkins MA, Casey G, Brenner H, Chang-Claude J, et al. Modifiable pathways for Colorectal cancer: a mendelian randomisation analysis. Lancet Gastroenterol Hepatol. 2020;5:55–62. https://doi.org/10.1016/s2468-1253(19)30294-8
doi: 10.1016/s2468-1253(19)30294-8
pubmed: 31668584
Rath AA, Lam HS, Schooling CM. Effects of selenium on coronary artery Disease, type 2 Diabetes and their risk factors: a mendelian randomization study. Eur J Clin Nutr. 2021;75:1668–78. https://doi.org/10.1038/s41430-021-00882-w
doi: 10.1038/s41430-021-00882-w
pubmed: 33828238
Chen L, Fan Z, Sun X, Qiu W, Mu W, Chai K, Cao Y, Wang G, Lv G. Diet-derived antioxidants and nonalcoholic fatty Liver Disease: a mendelian randomization study. Hepatol Int. 2023;17:326–38. https://doi.org/10.1007/s12072-022-10443-3
doi: 10.1007/s12072-022-10443-3
pubmed: 36352064
Fu S, Zhang L, Ma F, Xue S, Sun T, Xu Z. Effects of Selenium on chronic Kidney Disease: a mendelian randomization study. Nutrients. 2022;14. https://doi.org/10.3390/nu14214458
Deng MG, Cui HT, Nie JQ, Liang Y, Chai C. Genetic association between circulating selenium level and the risk of schizophrenia in the European population: a two-sample mendelian randomization study. Front Nutr. 2022;9:969887. https://doi.org/10.3389/fnut.2022.969887
doi: 10.3389/fnut.2022.969887
pubmed: 36082036
pmcid: 9445556
Chen J, Ruan X, Yuan S, Deng M, Zhang H, Sun J, Yu L, Satsangi J, Larsson SC, Therdoratou E, et al. Antioxidants, minerals and vitamins in relation to Crohn’s Disease and ulcerative Colitis: a mendelian randomization study. Aliment Pharmacol Ther. 2023;57:399–408. https://doi.org/10.1111/apt.17392
doi: 10.1111/apt.17392
pubmed: 36645152
Sutherland JP, Zhou A, Hyppönen E, Vitamin D. Deficiency increases Mortality Risk in the UK Biobank: a nonlinear mendelian randomization study. Ann Intern Med. 2022;175:1552–9. https://doi.org/10.7326/m21-3324
doi: 10.7326/m21-3324
pubmed: 36279545